Shanghai Pharmaceuticals (02607): The ANDA for Tegrelol Tablets has been approved by the US FDA.

The Zhijing Financial APP news reported that Shanghai Pharmaceuticals (02607) announced that its subsidiary Changzhou Pharmaceutical Factory Co., Ltd. (referred to as "Changzhou Pharmaceutical Factory") has recently received a notification from the Food and Drug Administration of the United States ("FDA"). The abbreviated new drug application ("ANDA") for Tegretol tablets has obtained final approval for listing.